We will upload information about the latest recipients to have been awarded HRC funding for all of our funding opportunities as this information becomes officially available.

The information provided is for ‘year to date’ funding.

Previous Recipient List

  • 2013 Funding Round
    Dr Marianne Elston
    The University of Auckland
    Thyrotoxicosis: Assessment of ethnic differences in presentation and outcome
    $150,000
    36 months
  • 2008 Funding Round
    Dr Daniel Exeter
    The University of Auckland
    Immunisation disparities and vaccine-preventable diseases in New Zealand
    $133,004
    36 months
  • 2011 Funding Round
    Dr Justin Fernandez
    The University of Auckland
    Can Low Dose Fluoride Therapy Increase Bone Strength in Osteoporosis?
    $139,100
    36 months
  • 2012 Funding Round
    Dr Louise Foley
    The University of Auckland
    Profiling and Modifying Physical Activity and Sedentary Behaviour: New Paradigm
    $149,998
    36 months
  • 2009 Funding Round
    Dr Elizabeth Forbes
    Malaghan Institute of Medical Research
    New strategies for the treatment and prevention of food allergy
    $150,000
    36 months
  • 2014 Funding Round - Emerging Researcher First Grant
    Dr Alan Gamble
    University of Otago, Dunedin
    Bioorthogonal prodrug activation for targeted chemotherapy
    $144,275
    36 months
  • 2018 Emerging Researcher First Grant
    Dr Rosemary Gibson
    Massey University
    The role of sleep in healthy ageing and living well with dementia
    $249,998
    36 months
  • 2014 Funding Round – Emerging Researcher First Grant
    Dr Natasha Grimsey
    The University of Auckland
    Characterising cannabinoid receptor 2 polymorphisms implicated in mental illness
    $149,732
    36 months
  • 2011 Funding Round
    Dr Richard Hall
    Institute of Environmental Science Research Limited
    Hunting the Silent Majority: Unknown Viruses in Human Gastrointestinal Disease
    $150,000
    36 months
  • 2016 funding round - Feasibility Study
    Dr June-Chiew Han
    University of Auckland
    Disturbed energetics in heart failure: its associatin with t-tubule disruption
    $111,000
    36 months
  • 2014 Funding Round – Emerging Researcher First Grant
    Dr Elena Harjes
    Massey University, Palmerston North
    Screening for APOBEC3B inhibitors: A new approach to fighting breast cancer
    $150,000
    24 months
  • 2011 Funding Round
    Dr Joanne Harvey
    Victoria University of Wellington
    Analogues of Zampanolide: Design, Synthesis and Anti-Cancer Activity
    $126,600
    36 months
  • 2012 Funding Round
    Dr Dione Healey
    University of Otago, Dunedin
    Comparing ENGAGE and Triple P: Treatment Programmes for Hyperactive Pre-schoolers
    $150,000
    36 months
  • 2014 Funding Round – Emerging Researcher First Grant
    De Jacqueline Henderson
    University of Canterbury
    Neurodevelopmental outcomes of children exposed to methadone during pregnancy
    $146,243
    24 months
  • 2016 funding round - Emerging Researcher First Grant
    Dr Claire Heppenstall
    University of Otago, Christchurch
    Utilising a prognostic indicator to guide deprescribing in
    $145,459
    24 months
  • 2008 Funding Round
    Dr Jade Hollis-Moffatt
    University of Otago, Dunedin
    Understanding the genetic basis of hyperuricemia in Te Tairawhiti, New Zealand
    $137,707
    18 months
  • 2013 Funding Round
    Dr Taisia Huckle
    Massey University, Auckland
    Restricting the availability of alcohol to reduce alcohol-related harm in New Zealand
    $149,363
    36 months
  • 2012 Funding Round
    Dr Matloob Husain
    University of Otago, Dunedin
    The Role of Multisubstrate Deacetylase HDAC6 in Influenza A Virus Replication
    $150,000
    36 months
  • 2008 Funding Round
    Ms Louise Ihimaera
    Massey University
    Māor Whanau participation in mental health service delivery
    $114,497
    24 months
  • 2014 Funding Round - Emerging Researcher First Grant
    Dr Christopher Jackson
    University of Otago/Southern District Health Board, Dunedin
    Primary rectal cancer management in advanced disease with chemotherapy
    $145,529
    36 months